Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...

The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the potential.

"This enhanced understanding of the regulation of spermatogenesis provides the foundation for further studies including ...

Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene ...

JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025.

Discover LumiSTAR, a Taiwan biotech leader combining iPSC technology and patented bioimaging (LumiRDT) to revolutionize drug discovery and cell therapy platforms. News Home Page ...

With stem cell treatments, ischemic stroke patients have shown improvement in motor function. Swiss Medica’s stem cell therapy and research Swiss Medica, a leading stem cell clinic , is at the ...

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...